Silence Therapeutics plc logo

Silence Therapeutics plc Employee Directory

Biotechnology ResearchEngland, United Kingdom51-200 Employees

Silence Therapeutics plc is a biotechnology research company headquartered in London, United Kingdom, at 72 Hammersmith Road, London, England W14 8th. The firm focuses on RNA interference (RNAi) technologies, developing siRNA-based therapies using its mRNAi GOLD platform and associated liver-targeting capabilities. It cites over 20 years of RNAi experience and pursues a deep pipeline of siRNAs designed to address diseases with a genetic basis. Silence Therapeutics positions itself as a partner for pharmaceutical companies seeking access to siRNA discovery and development through its platform. The company's publicly accessible website is https://silence-therapeutics.com, and it employs between 51 and 200 people.

Find Silence Therapeutics plc employees' phone numbers or email addresses

Silence Therapeutics plc Global Highlights

Location
Employees

Europe
82

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    46
  • Germany
    33
  • Poland
    1
  • Switzerland
    1
  • Sweden
    1

North America
12

Minus sign iconPlus sign icon
  • United States Of America
    11
  • Canada
    1

Silence Therapeutics plc's Leadership

  • Chief Scientific Officer at Silence Therapeutics plc
    M. W. L.
    Chief Scientific Officer
  • Vice President Drug Discovery at Silence Therapeutics plc
    S. S.
    Vice President Drug Discovery
  • Vice President - Information Technology at Silence Therapeutics plc
    L. E.
    Vice President - Information Technology
  • Vice President And Head Of Clinical Development at Silence Therapeutics plc
    R. J.
    Vice President And Head Of Clinical Development
  • Head Of Nucleic Acids Bioanalytics at Silence Therapeutics plc
    C. L.
    Head Of Nucleic Acids Bioanalytics
  • Svp, Chief Technical Operations Officer at Silence Therapeutics plc
    J. P. G.
    Svp, Chief Technical Operations Officer
  • Vice President, Group Leader Oligonucleotide Chemistry at Silence Therapeutics plc
    L. B.
    Vice President, Group Leader Oligonucleotide Chemistry
  • Vp, Head Of Clinical Operations at Silence Therapeutics plc
    R. M.
    Vp, Head Of Clinical Operations

Silence Therapeutics plc Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Program & Project Management
  • Finance
  • Operations
  • Consultant
  • Other
  • Engineering
  • Biotechnology
  • Human Resources
  • Business
  • Administrative
  • Legal
  • Accounting
  • Sales

Contact profiles from Silence Therapeutics plc

Name
Title
Contact
Location
Last Update
  • Svp, Chief Technical Operations Officer at Silence Therapeutics plc
    J. P. G.
    Svp, Chief Technical Operations Officer
    Germany, Bavaria
    Sep 21, 2026
  • Chief Scientific Officer at Silence Therapeutics plc
    M. W. L.
    Chief Scientific Officer
    Sweden
    Oct 09, 2026
  • Vice President, Group Leader Oligonucleotide Chemistry at Silence Therapeutics plc
    L. B.
    Vice President, Group Leader Oligonucleotide Chemistry
    Germany, Brandenburg
    Sep 30, 2026
  • Vp, Head Of Clinical Operations at Silence Therapeutics plc
    R. M.
    Vp, Head Of Clinical Operations
    United Kingdom, England
    Sep 21, 2026
  • Vice President Drug Discovery at Silence Therapeutics plc
    S. S.
    Vice President Drug Discovery
    Germany, Schleswig-Holstein
    Sep 21, 2026
  • Principal Scientist, Head Of Molecular Design Biology at Silence Therapeutics plc
    E. M.
    Principal Scientist, Head Of Molecular Design Biology
    Germany, Schleswig-Holstein
    Sep 30, 2026
  • Senior Director, Head Of Fp & A at Silence Therapeutics plc
    C. E. C. A.
    Senior Director, Head Of Fp & A
    United Kingdom, England
    Aug 28, 2026
  • Vice President, Corporate Controller at Silence Therapeutics plc
    M. V.
    Vice President, Corporate Controller
    United Kingdom, England
    Sep 13, 2026
  • Senior Director, Head Of Late-Stage Cmc at Silence Therapeutics plc
    K. M.
    Senior Director, Head Of Late-Stage Cmc
    Switzerland
    Sep 21, 2026
  • Vice President - Information Technology at Silence Therapeutics plc
    L. E.
    Vice President - Information Technology
    United Kingdom, England
    Sep 21, 2026

Frequently Asked Questions

What is Silence Therapeutics plc known for?

Minus sign iconPlus sign icon
Silence Therapeutics plc was founded in 1999 and operates in the Biotechnology Research industry. You can contact Silence Therapeutics plc's main corporate office by phone at . Explore Silence Therapeutics plc's company overview page for more information.

What is Silence Therapeutics plc's most common email format?

Minus sign iconPlus sign icon
Silence Therapeutics plc employees' email format typically follows the pattern of F.Last@silence-therapeutics.com. Trying to find reliable and up-to-date employee contact data? Find more Silence Therapeutics plc email formats with LeadIQ.

How many employees does Silence Therapeutics plc have currently?

Minus sign iconPlus sign icon
Silence Therapeutics plc has approximately 91 employees as of October 2026. These team members are located across 2 continents, including Europe and North America.

Who are Silence Therapeutics plc's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2026, Silence Therapeutics plc's key employees include:

  • Chief Scientific Officer: M. W. L.
  • Vice President Drug Discovery: S. S.
  • Vice President - Information Technology: L. E.
  • Vice President And Head Of Clinical Development: R. J.
  • Head Of Nucleic Acids Bioanalytics: C. L.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.